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Summary: An evaluation of enzyme immunoassays for determination of thyroxine in serum (EMIT ABA thyroxine
assay, Syva Corp., ENZYMUN assay thyroxine, Boehringer Mannheim) and of thyroxine binding index (ENZYMUN
assay TBI1), Boehringer Mannheim) is presented. The precision of the enzyme immunoassays was adequate (coefficients
of variation ranged from day to day with EMIT from 3-11% and with ENZYMUN from 4-11%). Both assays are
specific and easy to perform. About 20 unknown samples can be analyzed in duplicate by EMIT within 60 minutes
and by ENZYMUN within 250 minutes. A comparison of the results obtained by enzyme immunoassays and radio-
immunoassay in a series of about 100 patients showed a good correlation between both methods. The precision of
the ENZYMUN TBI assay was adequate (coefficient of variation from day to day 4.9%) and the thyroxine/TBI-ratio
correlated well with the thyroxine/TBG-ratio.
Erprobung von Enzym-Immuno-Tests zur Bestimmung von Thyroxin (EMIT, ENZYMUN) und des Thyroxin-Bin-
dungs-Index
Zusammenfassung: Es wird über eine Erprobung von Enzym-Immuno-Tests zur Bestimmung von Thyroxin im Serum
(EMIT ABA Thyroxin Test, Syva Corp., ENZYMUN-Test Thyroxin, Boehringer Mannheim) und des Thyroxin-Bin-
dungs-Index (ENZYMUN-Test TBI1), Boehringer Mannheim) berichtet. Die Präzision der Enzym-Immuno-Tests war
ausreichend (die Variationskoeffizienten lagen von Tag zu Tag mit EMIT bei 3—11% und mit ENZYMUN bei 4—11 %).
Beide Tests sind spezifisch und rasch durchführbar. Etwa 20 unbekannte Proben können als Doppelbestimmungen
mit EMIT in 60 Minuten und mit ENZYMUN in 250 Minuten durchgeführt werden. Ein Vergleich der Ergebnisse,
welche mit den Enzym Jmmuno-Tests und einem Radioimmunotest bei einer Serie von etwa 100 Patienten erhalten
würden, zeigte eine gute Übereinstimmung beider Methoden. Die Präzision des ENZYMUN TBI-Tests war ausreichend
(Variationskoeffizient von Tag zu Tag 4,9%) und der Thyroxin/TBI-Quotient korrelierte gut mit dem Thyroxin/TBG-
Quotienten.
Introduction procedure (9-10) (ENZYMUN assay thyroxine,
, . ,. - · *- * ENZYMUN assay TBI, Boehringer Mannheim, D-6800Enzyme immunoassays have gained increasing interest . y ' 6 '
r
 y
 · * . 7 . ' ' * 7 ;· 6 . Mannheim), have recently become commerciallyfor routine analysis m the last few years. In comparison -\ \
with radioimmunoassay this technique has the advantage ^ai a e;
that no radioactive material is used, the standard equip- The results of an evaluation of these enzyme immuno-
ment of routine laboratories can be used, and the reagents assays are presented m this study,
have a longer sheif life. A number of enzyme immunoassays
 1} Jhe ^  mjne ha$ recently been changed to ENZYMUN.
have already been mechanized and are successfully applied jest TBK.
in routine laboratories (1-6). 2) Abbreviations: EMITR = Enzyme multiplied immunoassay
technique, ELISA = Enzyme linked immunosorbent assay,
Enzyme immunoassays2) for the determination of ENZYMUNR = trade name for various enzyme immunoassays
thyrosine ^ d thyroxine binding inde* (TBI).based ^^^iS^'^SSSSSSKS
either on the EMIT technique (7-8) (EMIT thyroxine
 FTi - free thyroxine index, T4 = thyroxine, T3 = triiodo-
assay, Syva Corp., Palo Alto, U.S.A.) or on an ELISA thyronine.
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Materials and Methods
Materials
The reagents for the EMIT ABA thyroxine assay were provided
by E. Merck (D-6100 Darmstadt). Reagents for the ENZYMUN
assays, thyroxine and TBI were from Boehringer Mannheim
(D-8132 Tutzing). Kits for the determination of thyroxine-
binding globulin (RIA-GNOST, TBG) were purchased from
Behring-Werke (D-3550 Marburg). Triiodothyronine, Triiodo-
thyroacetic acid and tetraiodothyroacetic acid were a generous
gift from Henning (D-1000 Berlin). Z,-thyroxine was purchased
from Sigma (D-8021 Taufkirchen).
Enzyme immunoassays
Thyroxine was assayed by the EMIT ABA thyroxine assay
designed for use with the ABA 100 Bichromatic Analyzer
(Abbott, D-6070 Langen) equipped with an auxiliary dispenser.
Determinations of thyroxine and TBI by ENZYMUN assays
were carried out with an Eppendorf system 5090 (Eppendorf,
D-2000 Hamburg 63) at a wavelength of 405 nm.
All of these enzyme immunoassays (EMIT, ENZYMUN) were
performed according to the manufacturer's instructions. Un-
known samples were analyzed by EMIT in duplicate and by
ENZYMUN in triplicate, as recommended by the manu-
facturers.
Radio immunoassays
Thyroxine determinations by radioimmunoassay were carried out
with a double antibody technique, which is used as the present
routine procedure.
20 μΐ of serum or thyroxine standard (A), 400 μ\ of barbital
buffer containing [125IJL-thyroxine (B), 200 μ\ of antiserum
against thyroxine (C) and 100 μ\ of precipitating antiserum (D)
are incubated for 18 hours at room temperature. The samples
are then centrifuged for 15 minutes at 2400 g and the super-
natant is discarded. The pellet is washed once with 1 ml of bi-
distilled water. The antibody-bound radioactivity is measured
using gamma counters (Berthold, D-7547 Wildbad; Packard,
D-6000 Frankfurt/M.). All samples were analyzed in duplicate.
Standard curves were calculated by "spline function" (11) using
a Diehl Alphatronic calculator (Diehl, D-8500 N rnberg).
Reagents
(A) Thyroxine-free serum was prepared according to Meinhold
& Wenzel (12). Charcoal (200 g, Norit A, Serva, D-6900 Heidel-
berg) was added to pool serum (11), stirred overnight at 4°C
and then centrifuged for 8 hours at 20 000 g. The supernatant
was filtered using quartz wool and then spiked with £-thyroxine
(Henning, D-1000 Berlin) (19-618 nmol/1).
(B) Barbital buffer (pH 8.4) contains: 80 mmol/1 barbital
(5,5' diethyl-barbituric acid-sodium salt) (Merck, D-6100 Darm-
stadt), 10 mg/1 rabbit γ-globulin (Serva, D-6900 Heidelberg),
1 g/1 human serum albumin (Behring, D-3550 Marburg), 1.108
mmol/1 ANS (ammonium salt of l-anilino-8-naphthalene-sulfonic
acid (Serva, D-6900 Heidelberg), 72.5 pmol/1 [l2Sl]L-thyroxine
(specific radioactivity 28749 MBq/Mmol, Rohstoffeinfuhr, D-4000
D sseldorf), 0.5 mmol/J merthiolate (sodium salt of ethylmercuri-
thiosalicylic acid) (Merck, D-6100 Darmstadt).
(C) Thyroxine-bovine-serum-albumin-conjugate was prepared
according to Oliver (13) and Hesch (14) by coupling /,-thyro-
xine-ethylester-hydrochloride (Henning, D-1000 Berlin) to bovine
serum albumin (Behring, D-3550 Marburg) using l-ethyl-3(3-
dimethylaminopropyl)-carbodiimidehydrochlpride (Serva,
D-6900 Heidelberg). Two mg of thyroxine-bovine-serunv '
albumin-conjugate dissolved in 1 ml complete Freund's adjuvant
and 9 g/1 sodium chloride solution (volumes 0.5 ml + 0.5 ml)
were subcutaneously injected at various places on the back of
rabbits every 14 days. The reaction medium of the assay contains
thyroxine antiserum in a final dilution of 1:5400 (affinity
constant 2.5 X 1010l/mol).
(D) As precipitating antiserum anti-rabbit ^-globulin .from
donkey (Wellcome, D-3006 Gro burgwedel) was used (final
dilution in the reaction medium 1:144). Thyroxine-binding
globulin (TBG) was determined by use of the RIA-GNOST TBG
assay according to the instructions of the manufacturer.
Calculation of FTI and T4/TBG-ratio
FTI was calculated as thyroxine G*g/dl)/TBI, and T4/TBG-ratio
as thyroxine (Mg/dl) X 10 O O/TBG (mg/1).
Reference ranges
Reference ranges for thyroxine, TBG, FTI and T4/TBG-ratio
were used as indicated by the manufacturers of the various kits.
With our radioimmunoassay for determination of thyroxine the
reference range used was 51.5-167.3 nmol/1. This reference range
was established by the analysis of 150 samples from clinically
euthyroid patients (age: 20-65 years). As the results showed a
normal distribution the reference range was calculated from the
mean value and two standard deviations.
Furthermore, the various reference ranges were examined for
their validity for the patient collective tested in this study. It
was found that the median of the results obtained with this
collective was in each case in the middle of the corresponding
reference range. Therefore the use of the mentioned reference
ranges appeared to be justified.
Thyroxine values given in Mg/dl are converted into nmol/1 by
multiplication with 12.87.
Results
Precision
With various commercial control sera the coefficients of
variation ranged from day to day with EMIT from 3-5%,
with ENZYMUN from 4-7% and with the radioimmuno-
assay from 6—8% (tab. 1). At low thyroxine concen-
trations (25—30 nmol/1) coefficients of variation of
about 11% were found with the enzyme immunoassays.
These precision data refer to duplicate determinations.
Accuracy
Average recoveries of thyroxine added to pooled thy-
roxine-free human serum are shown in table 2. At
various thyroxine concentrations between 64 and
260 nmol/1 the recovery with EMIT was 94-100%,
with the ENZYMUN assay 96-103%, and with the
radioimmunoassay 97—107%.
Furthermore the results measured by ENZYMUN
thyfoxine assay and radioimmunoassay in 107
specimens from patients were compared. The least-
squares regression analysis (fig. 1) showed the slope of
the line to be 0.97. The value of the intercept was 2.7
nmol/1. The correlation between the results was good
(r = 0.972). The mean values obtained by ENZYMUN
and radioimmunoassay were 121.2 ± 56.5 nmol/1 and
122,0 ± 56.5 nmol/1 respectively. A significant differ-
ence between the results of both methods was not
present (t-value 0.59). Reproducible deviations of
more than 30% between the results of both assays
occurred in 2 out of 107 cases. Only one of these
discrepancies was clinically relevant: a hypothyroid
patient was erroneously classified euthyroid by the
ENZYMUN assay.
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Tab. 1. The precision from day to day of the ENZYMUN-, EMIT ABA assay and radioimmunoassay for determination of thyroxine
in serum. Assays were performed in duplicate on various days as indicated and the mean values were used for calculation of the
precision.
ENZYMUN
Calibrators
25.7 nmol/1
32.2 nmol/1
38.6 nmol/1
X
(nmol/1)
_
34.0
38.0
CVa n*>
(%)
— —(11.2) 10
( 6.9) 17
EMIT ABA
χ
(nmol/1)
28.6
—
-
CV n
(%)
(11.4) 20
__ __
- -
Radioimmunoassay
X
(nmol/1)
_
_
-
CV(%)
__
-
n
-
51.5 nmol/1
Boehiinger Mannheim
control serum
Lederle RIA control serum I
Lederle RIA control serum II
88.8 ( 4.3) 11
118.4 ( 6.5) 24
260.0 ( 4.0) 16
54.8 ( 5.9) 20
113.3 ( 4.5) 51
249.7 ( 3.6) 38
103.4 ( 6.9) 29
247.0 ( 8.0) 28
a) mean value (nmol/1) with coefficient of variation in parentheses.
b) number of days.
Tab. 2. The recovery of thyroxine by ENZYMUN-, EMIT ABA assay and radioimmunoassay in spiked serum samples. Determinations
were performed in duplicates on various days.
L -Thyroxine Recovery
ENZYMUN assay
(nmol/l)
64.4
128.7
193.1
257.4
(nmol/1)
64.4
132.6
186.6 .
245.8
(%)
100
103
97
96
n1
3
3
3
3
EMIT ABA assay
(nmol/1)
64.4
121.0
182.8
244.5
(%)
100
94
95
95
n
6
3
6
5
Radioimmunoassay
(nmol/1)
66.9
137.7
186.6
253.5
(%)
105
107
97
99
n
3
3
3
3
1) number of days.
0.0 5.0 10.0 15.0 20.0
Thyroxine (Radioimmunoassay)
Fig. 1. Serum thyroxine concentrations as measured by enzyme
immunoassay (ENZYMUN) and« radioimmurioassay
(n- 107). Slope: 0.97, intercept: 2.7 nmol/1, correlation
coefficient: 0.972. Open circles represent serum samples
with elevated concentrations of TBG (> 30 mg/1).
The comparison of the results (n=102) obtained by
the EMIT ABA thyroxine assay and radioimmunoassay
also showed a sufficient correlation of both methods
(fig. 2). The values of slope and intercept were 0.80
and 18.9 nmol/1. The coefficient of correlation was
[nmol/l]
300l·
•200
100
250
120.0
15.0
100
αο 100 200 300 [nmol/l]
QO 5.0 10.0 15.0 20.0 t/ig/dl]
Thyroxine (Radioimmunoassay)
Fig. 2. Serum thyroxine concentrations as measured by enzyme
immunoassay (EMIT) and radioimmunoassay (η = 102).
Slope: 0.80, intercept: 18.9 nmol/1, correlation coeffi-
cient: 0.935. Open circles represent serum samples with
elevated concentrations of TBG (> 30 mg/1).
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r = 0.935. The mean value of the results determined
by EMIT (y = 114.1 ± 45.2 nmol/1) was 3.7% lower
than that found with radioimmunoassay (x = 118.5 ±
52.7 nmol/1). The t-value was 2.34 (p < 0.0125).
Reproducible differences of more than 30% between
the results of both methods occurred in 4 out of 102
cases. Only two of these discrepances were clinically
relevant: one hypo- and one hyperthyroid patient were
falsely classified euthyroid by the EMIT assay.
The correlation between these enzyme immunoassays
and the radioimmunoassay was satisfactory, also when
the samples contained elevated concentrations of
thyroxine-binding globulin (fig. 1, 2).
Specificity
The specificity of the enzyme- and radioimmunoassays
for the determination of thyroxine was tested by the
determination of the cross-reactivity with structurally
related compounds. The results obtained with spiked
thyroxine-free human serum samples are shown in
table 3. For each drug the concentration was determined
at which it exerts an absorbance or counts per minute
equivalent to 25.7 nmol/1 thyroxine in the corresponding
enzyme- or radioimmunoassay. Triiodpthyronine and the
two thyroxine metabolites triiodothyroacetic acid and
tetraiodothyroacetic acid (15) showed a distinctly
stronger cross-reaction iii the EMIT assay than in the
ENZYMUN- and radioimmunoassay. As the reference
range of these compounds, however, is very low, a
relevant interference is usually not to be expected in
any of these tests.
Interferences
Hemoglobin concentrations up to 1.0 g/1 showed no
interference in both enzyme immunoassays.
The influence of lipemia on these tests was studied with
lipemic sera (n = 15; triglyceride concentration: x:
11.0 mmol/1, range 3.4-19.8 mmol/1), which were assayed
undiluted and after dilution (1:2) with 9 g/1 sodium
chloride solution. Results of diluted samples were multi-
plied with the dilution factor.
Tab. 3. Cross-reactivity of triiodothyronine and thyroxine metabolites1) in enzyme immunoassays (EMIT, ENZYMUN) and. a radio-
immunoassay (RIA) for determination of thyroxine.
Compound
Thyroxine
Triiodothyronine
Triiodothyroacetic acid
Tetraiodothyroacetic acid
Reference range
nmol/1
51.5-167.3
1.23-3.69
<0.163)
1.0-3.9
EMIT
nmol/12)
25.7
29.2
59.6
22.7
ENZYMUN
nmol/12)
25.7
35.4
>1600
57.5
RIA
nmol/12)
25.7
33.8
>1600
60.2
1) Substances were added to thyroxine-free human serum.
2) Concentration resulting in an absorbance or in counts per minute equivalent to 25.7 nmol/1 thyroxine.
3) Estimated serum concentration (15).
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Fig. 3. Deviations between thyroxine determinations by EMIT
and radioimmunoassay (calculated as thyroxine (nmol/1)
EMIT/ thyroxine (nmol/1) radioimmunoassay) in relation
to the bilirubin concentrations of the corresponding
serum samples (n = 30). The dotted line indicates identi-
cal results obtained with both radio- and enzyme immu-
noassay.
0 100 200 300 400 500 600 700
Bilirubin [fimol/l]
Fig. 4. peviations between thyroxine determinations by
ENZYMUN and radioimmunoassay in relation to the
bilirubin concentrations of the corresponding serum
samples (n = 30). For further explanation s"ee legend of
fig. 3.
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No interference was found with the ENZYMUN assay
(thyroxine (nmol/1): x: 86.2; diluted samples, x: 87.5).
With the EMIT assay lower thyroxine concentrations
were measured in undiluted samples (x: 68.2 nmol/1;
diluted samples: x: 81.1 nmol/1).
In icteric sera higher thyroxine concentrations were
found by the enzyme immunoassays than by radio-
immunoassay. In about 50% of the determinations the
results of the enzyme immunoassays showed a reprodu-
cible deviation of more than 30% from those of the
radioimmunoassay. However a clear-cut relationship
between these discrepancies and the bilirubin concen-
tration could not be detected (fig. 3,4). If serum
samples were spiked with bilirubin, no interference was
found with the radio- and enzyme immunoassays at bili-
rubin concentrations up to 600 jumol/l. So far it cannot
be concluded whether bilirubin or another yet unidenti-
fied agent which might be present in icteric sera, was
responsible for the discrepancies observed. Moreover,
it is not clear whether the interference present was in
the radio- or in the enzyme immunoassays. Further
investigations of this phenomenon are in progress.
50
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Fig. 5. Correlation between thyroxine/TBG- and thyroxine/TBI-
ratio (n = 77). Open circles represent serum samples with
elevated concentrations of TBG (> 30 mg/1). -.- regression
line in the presence of normal TBG concentrations
(y = 3.35 x - 2.92); - regression line in the presence of
elevated TBG concentrations (> 30 mg/1) (y = 3.81
x-1.01).
Determination of free thyroxine index by
ENZYMUN TBI assay
An enzyme immunoassay for the determination of the
thyroxine binding index (TBI), based on the ENZYMUN
thyroxine assay, has been developed (10), and it is
commercially available. This test can be used like tri-
iodothyronine (T3) uptake tests for an indirect estimate
of the protein binding of thyroid hormones. T3 uptake
tests have proved clinically useful and have been
combined with measurement of total thyroxine (16)
to yield free thyroxine index (FTI; calculated as T4/T3
uptake or TBI), which has been found to correlate with
both the clinical state of patients and the free T4 con-
centration as measured directly (17). Recently however
it was demonstrated that the T4/thyroxine-binding
globulin (TBG) ratio provides a better index of
thyroid function than does FTI (18, 19). Therefore we
compared the FTI determined by the ENZYMUN
assay with the T4/TBG ratio. The correlation between
both ratios was good. The serum samples tested con-
tained concentrations of thy roxine-bin ding globulin
between 16 and 48 mg/1 (fig. 5). In the presence of
elevated TBG concentrations (> 30 mg/1) the regression
line appears to have a higher slope than in the presence
of TBG concentrations in the normal range. Dis-
crepancies concerning the classification of patients into
eu-, hypo- or hyperthyroid occurred in 6 out of 77 cases.
In 5 of these cases the T4/TBG ratio was slightly below
the normal range, whereas the T4/TBI ratio was normal.
Three of these patients were clinically euthyroid. A
relevant discrepancy was present in only one case, which
was classified euuiyroid by T4/TBG ratio and hyper^
thyroid by FTI. The clinical state of this patient was
hyperthyroid. It has to be considered however, that the
reference ranges used are preliminary and still the subject
of investigation. The precision of the ENZYMUN TBI
assay was acceptable. From day to day a coefficient of
variation of 4.9% was obtained (x = 1.0; n = 20; mean
values of duplicate determinations).
Discussion
Both enzyme immunoassays (EMIT, ENZYMUN) for
determination of thyroxine were precise and accurate.
As the precision of the ENZYMUN and EMIT assay was
satisfactory the performance of the duplicate determ-
inations of unknown samples appears to be adequate.
The results of the enzyme immunoassays correlated
well with those obtained by a radioimmunoassay. With
few exceptions, the subsequent clinical interpretation was
identical for all three methods used.
The linear regression analysis of the results obtained by
EMIT and radioimmunoassay points to a proportional
error of about 20% and to a constant error of 18.9
nrriol/1 (20). The results of the EMIT assay tended to be
higher at thyroxine concentrations below 90 nmol/1 and
lower at concentrations above this value than the results
determined by radioimmunoassay.
Similar regression constants were found when the EMIT
assay was performed with an "Autochemist" analyzer
(21), a Kem-O-Mat analyzer (22) or, as in our study,
with an ABA 100 analyzer (23).
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Accordingly, the recovery at thyroxine concentrations
above 129 nmol/1 was only about 95% (tab. 2) and at
lower concentrations (38.6 nmol/1) 107% (23). As the
Syva Corp. recommends an upper limit of the euthyroid
range which is about 10% lower and a lower limit which
is about 10% higher than that used with the radioimmu-
noassay, these deviations had no relevant influence on
the clinical interpretation of the results.
Both enzyme immunoassays are easy to perform. 20
unknown duplicate samples can be analyzed by the EMIT
ABA assay within 60 minutes and by the. ENZYMUN
assay within 250 minutes.
The ENZYMUN TBI assay seems to be suitable for an
indirect estimate of the protein binding of thyroid
hormones. A T3-uptake test based on the EMIT technique
has also been described (24). The direct measurement of
TBG has the advantage that it is better standardized than
indirect methods, and it is independent of the endo-
genous thyroid hormone concentration. Therefore the
direct determination of TBG is preferred by various
authors (25, 26).
In summary it is concluded from our results that the
enzyme immunoassays tested (EMIT, ENZYMUN) can
be used as well as radioiminunoassay for the determ-
ination of thyroxine and TBI in serum. If only in-vitro
procedures are considered, the determination of an
index of free thyroxine is reportedly sufficient for
primary thyroid diagnostic and therapy control in
about 60—70% of all cases of an unselected patient
collective (27). Thus a relatively large proportion of
in vitro thyroid diagnostic may be reliably conducted
by the enzyme immunoassays tested in this study.
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